original articlesbreast tumorsClinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer
breast tumors
Under an Elsevier user license
open archive
Key words
breast
cancer
triple negative
tumor-infiltrating lymphocytes
chemotherapy
survival
Cited by (0)
- †
Both authors contributed equally to the work.
Copyright © 2015 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.